
Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Legal Action and Investor Rights - Shareholders who purchased HealthEquity securities may be entitled to compensation through a contingency fee arrangement, with a class action being prepared to recover investor losses [2] - To join the prospective class action, investors can submit their information through the provided link or contact the law firm directly [2] Group 2: Company Performance and Market Reaction - HealthEquity's stock experienced a significant decline of 17% on March 19, 2025, following an article that reported the company's missed profit estimates and weak guidance due to increased costs from cyber threats and fraud [3]